← Open Payments lookup

RAPHAEL MORRIS: Open Payments

NPI 1801811104 · DEL MAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$721 in 24 payments from 8 companies in 2025. Trend: 2023 $722 · 2024 $285 · 2025 $721

Food & beverage: $619Education: $101
CompanyPaymentsAmount
Alkermes, Inc.5$206
Vanda Pharmaceuticals Inc.6$144
Teva Pharmaceuticals USA, Inc.2$136
Neuronetics, Inc.5$96
Takeda Pharmaceuticals U.S.A., Inc.3$64
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$34
Neurocrine BioSciences, Inc.1$22
Otsuka America Pharmaceutical, Inc.1$19

Products named: LYBALVI, FANAPT, NEUROSTAR TMS THERAPY SYSTEM, TRINTELLIX, ARISTADA, AUSTEDO XR, CAPLYTA, INGREZZA.

Industry payments across CA — which companies pay providers there.